AADAM - Overview: ADAMTS13 Profile Interpretation
Technical interpretation of a profile to assist with the diagnosis of congenital, immune, or acquired thrombotic thrombocytopenic purpura including inhibitor studies
CRUO - Overview: Chromium Occupational Exposure, Random, Urine
Screening for occupational exposure
Diagnosis of small cell lung carcinoma (SCLC), large cell neuroendocrine carcinoma (LCNEC), amongst other tumors
HPVHL - Overview: Human Papillomavirus (HPV) High/Low Risk, In Situ Hybridization
Detecting human papillomavirus for both low-risk (6, 11) and high-risk (16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 82.) genotypes
HAPT - Overview: Haptoglobin, Serum
Confirmation of intravascular hemolysis
FIBAG - Overview: Fibrinogen Antigen, Plasma
Evaluation of fibrinogen deficiency Measuring fibrinogen in patients with elevated plasma levels of fibrin degradation products, patients receiving heparin, and in patients with antibodies to thrombin (following surgical use of topical...
10_IS - Overview: Factor X Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor X
F7_IS - Overview: Factor VII Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor VII
F2_IS - Overview: Factor II Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor II
11_IS - Overview: Factor XI Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor XI
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....